Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydroxyurea: an overview.

M R Stevens1

  • 1Bristol-Myers Squibb Immunology, Plainsboro, NJ 08540, USA. michael.stevens@bms.com

Journal of Biological Regulators and Homeostatic Agents
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the Sw-5 locus for tomato spotted wilt virus resistance in tomatoes using RAPD and RFLP analyses.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Construction of a llama bacterial artificial chromosome library with approximately 9-fold genome equivalent coverage.

Journal of biomedicine & biotechnology·2012
Same author

Chromosomal localization of two novel repetitive sequences isolated from the Chenopodium quinoa Willd. genome.

Genome·2011
Same author

Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in [corrected] HIV/AIDS.

British journal of pharmacology·2010
Same author

Simple sequence repeat marker development and genetic mapping in quinoa (Chenopodium quinoa Willd.).

Journal of genetics·2008
Same author

Molecular and cytological characterization of ribosomal RNA genes in Chenopodium quinoa and Chenopodium berlandieri.

Genome·2006
Same journal

Identification of circRNA-mediated competing endogenous RNA network in the development of bladder urothelial carcinoma.

Journal of biological regulators and homeostatic agents·2021
Same journal

Dimethyl fumarate attenuates lipopolysaccharide-induced acute lung injury by inhibiting inflammation and oxidative stress.

Journal of biological regulators and homeostatic agents·2021
Same journal

Expression of NLR and IL-1β and their predictive efficacy value in acute myocardial infarction patients treated with aspirin combined with clopidogrel.

Journal of biological regulators and homeostatic agents·2021
Same journal

CircRNA (circ_0008057) promotes uremic serum-mediated proliferation and migration of vascular smooth muscle cells via miR-370/PLk1 signaling pathway.

Journal of biological regulators and homeostatic agents·2021
Same journal

Overexpression of miR-150-5p alleviates lipopolysaccharide-induced A549 cell injury in type II alveolar epithelial cells by inhibiting the FSTL1 signaling pathway.

Journal of biological regulators and homeostatic agents·2021
Same journal

Efficacy of early oral and perioral physiotherapy on feeding autonomy in preterm infants: results of randomized controlled trials.

Journal of biological regulators and homeostatic agents·2021
See all related articles

Hydroxyurea is a versatile drug used for various conditions, including myeloproliferative and neoplastic diseases. Its potential in treating Human Immunodeficiency Virus (HIV) is under investigation, with careful management of side effects.

Area of Science:

  • Pharmacology
  • Hematology
  • Oncology

Background:

  • Hydroxyurea has a long history of clinical use for over a century.
  • It is a small molecule with diverse biological properties.
  • Its applications span myeloproliferative, neoplastic, and non-hematological diseases.

Purpose of the Study:

  • To review the established and emerging applications of hydroxyurea.
  • To highlight its potential role in Human Immunodeficiency Virus (HIV) treatment.
  • To discuss the management of its associated toxicities.

Main Methods:

  • Literature review of hydroxyurea's properties and clinical uses.
  • Analysis of its efficacy and safety profile in various diseases.
  • Examination of its pharmacokinetic and pharmacodynamic characteristics.

Related Experiment Videos

Main Results:

  • Hydroxyurea is effective in treating a range of hematological and neoplastic conditions.
  • Emerging research suggests potential benefits in Human Immunodeficiency Virus (HIV) therapy.
  • Dose-related bone marrow suppression is a primary toxicity, managed by dose titration.

Conclusions:

  • Hydroxyurea remains a valuable therapeutic agent due to its efficacy, ease of administration, and low cost.
  • Careful consideration of its use in pregnancy and during breastfeeding is essential.
  • Ongoing research may expand its clinical utility, particularly in Human Immunodeficiency Virus (HIV) treatment.